EcoDrugPlus

Gonadotropin Releasing Hormone Receptor

Ensembl ID : ENSFCAG00000001379
Gene Symbol: GNRHR
5 Cross references
242 Possible Orthologues:

Growth Hormone Releasing Hormone Receptor

Ensembl ID : ENSFCAG00000002543
Gene Symbol: GHRHR
5 Cross references
193 Possible Orthologues:

Growth Hormone Secretagogue Receptor

Ensembl ID : ENSFCAG00000011266
Gene Symbol: GHSR
5 Cross references
211 Possible Orthologues:

Guanylate Cyclase 1 Soluble Subunit Alpha 1

Ensembl ID : ENSFCAG00000010510
Gene Symbol: GUCY1A1
5 Cross references
203 Possible Orthologues:

Guanylate Cyclase 1 Soluble Subunit Alpha 2

Ensembl ID : ENSFCAG00000038721
Gene Symbol: GUCY1A2
5 Cross references
203 Possible Orthologues:

Guanylate Cyclase 1 Soluble Subunit Beta 1

Ensembl ID : ENSFCAG00000010512
Gene Symbol: GUCY1B1
5 Cross references
211 Possible Orthologues:

Heat Shock Protein 90 Alpha Family Class A Member 1

Ensembl ID : ENSFCAG00000000814
Gene Symbol: HSP90AA1
5 Cross references
262 Possible Orthologues:

High Mobility Group Box 1

Ensembl ID : ENSFCAG00000000200
Gene Symbol: HMGB1
5 Cross references
252 Possible Orthologues:

Histamine Receptor H1

Ensembl ID : ENSFCAG00000034897
Gene Symbol: HRH1
3 Cross references
186 Possible Orthologues:

Histamine Receptor H2

Ensembl ID : ENSFCAG00000024815
Gene Symbol: HRH2
5 Cross references
249 Possible Orthologues:

Histamine Receptor H3

Ensembl ID : ENSFCAG00000026486
Gene Symbol: HRH3
5 Cross references
117 Possible Orthologues:

Histamine Receptor H4

Ensembl ID : ENSFCAG00000010923
Gene Symbol: HRH4
5 Cross references
104 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).